Ethyl 2,3-dihydro-1H-pyrrolizine-7-carboxylate, 98%, 250mg

Ethyl 2-bromonicotinate, 95.0%, 250mg

Palmitoyl-glycine, 99.0%, 5g

4-(4-Bromophenyl)morpholine>98.0%(GC)(T)5g

Ethyl 4-(3-methoxyphenyl)-3-oxobutanoate, 97%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-2-methylpropanoic acid, 95%, 50mg

(4R)-4-PHENYL-2-(2-PYRIDYL)-4,5-DIHYDROOXAZOLE, 95%, 5g

(3S,3'S)-4,4'-(7-Chloropyrido[2,3-d]pyrimidine-2,4-diyl)bis(3-methylmorpholine), 95.0%, 500mg

Methyl 4-((4-methoxybenzyl)oxy)-3-oxobutanoate, 98%, 100mg

(4-Ethoxy-2-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

Ethyl 3-ethyl-4-methyl-1H-pyrrole-2-carboxylate, 95%, 1g

Manguera Versilic®, 3,0 mm, 6,0 mm, 50 m,

N-(4-CHLOROBENZYL)-N-(2,2-DIMETHOXYETHYL)-4-METHYLBENZENESULFONAMIDE, 95.0%, 1g